Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 620 | 802 | 1,838 | 4,207 | 14,176 |
| Cost of Goods | 321 | 457 | 1,070 | 3,390 | 8,238 |
| Gross Profit | 299 | 345 | 768 | 816 | 5,939 |
| Operating Expenses | 7,480 | 1,470 | 20,931 | 2,908 | 7,249 |
| Operating Income | -6,860 | -669 | -20,093 | -1,701 | -1,073 |
| Interest Expense | 0 | 38 | 221 | 0 | 1 |
| Other Income | 16 | 28 | -934 | 456 | 413 |
| Pre-tax Income | -6,844 | -679 | -21,248 | -1,245 | -662 |
| Income Tax | 58 | -58 | 1,958 | 10 | -169 |
| Net Income Continuous | -6,902 | -620 | -23,205 | -1,255 | -492 |
| Net Income | $-6,902 | $-620 | $-23,205 | $-1,255 | $-492 |
| EPS Basic Total Ops | -3.12 | -0.28 | -10.54 | -0.57 | -0.22 |
| EPS Basic Continuous Ops | -3.12 | -0.28 | -10.50 | -0.57 | -0.22 |
| EPS Diluted Total Ops | -3.12 | -0.28 | -10.54 | -0.57 | -0.22 |
| EPS Diluted Continuous Ops | -3.12 | -0.28 | -10.50 | -0.57 | -0.22 |
| EBITDA(a) | $-6,664 | $-352 | $-18,779 | $-1,673 | $-583 |